Research Projects & Grants

For Profit Organization

  • (CDA) SPERO Therapeutics / Dr. Jacinda Abdul-Mutakabbir, Role: PD/PI, SPERO Therapeutics, Status: Awarded


  • Determining the Mediators of Resistance to SPR206,a Novel Polymyxin Derivative, in Acinetobacter baumannii, Role: PD/PI, LLU - GRASP, (05/2021 - 04/2023) Status: Awarded

Non-Profit Organization

  • Determining the Mediators of Resistance to SPR206, a Novel Polymyxin Derivative, Role: PD/PI, Society of Infectious Disease Pharmacists, (12/2021 - 11/2022) Status: Awarded
  • Understanding the social and behavioral dimensions of COVID-19 vaccine acceptance among healthcare workers in Sierra Leone: Implications for community vaccine uptake, Role: PD/PI, Sabin Vaccine Institute, (11/2021 - 12/2022) Status: Awarded